Electronic Power Group Oxford To Power New Coupé
A lightweight electric motor designed by the Electronic Power Group at the University of Oxford is to power a new four-seat coupé, with track tests scheduled for the end of 2009.
A lightweight electric motor designed by the Electronic Power Group at the University of Oxford is to power a new four-seat coupé, with track tests scheduled for the end of 2009.
Oxford ArchDigital Archaeology, a spin-out company from the University of Oxford, has been chosen to deliver the new Finds Management Software for the Portable Antiquities Scheme.
Zyentia Ltd, Oxford University's latest spin-out company from the Chemistry Department, the third within the last half year, is based on technology that has the potential to solve major problems in protein therapies.
The 64th spin-out company from the University of Oxford, OxTox Ltd, will produce drug-testing kits for the police to use on drivers that are as reliable and easy to use as breathalysers for alcohol.
A new spin-out from Oxford University, Spinox, is aiming to devise novel ways to copy spiders' ability to spin silks. The new silks may be used for sutures or woven material for surgical implants, protective clothing and in sports equipment.
The latest spin-out company from Oxford University, Oxford Catalysts Ltd, plans to develop and exploit novel catalyst technology for the energy industry which is both cost-effective and environmentally friendly.
The latest spin-out company from Oxford University, Oxford Medical Diagnostics Ltd, hopes to develop a way of diagnosing disease simply by testing someone's breath.
Oxford University Innovation, the University of Oxford’s technology transfer company, announced today that a new spin-out company has been formed based on technology developed at the University. Intelligent Sustainable Energy (ISE) has received funding from Navetas Energy Management to develop a smart metering technology.
Oxford University's latest spin-out is the drug-discovery company InhibOx Ltd, which uses advanced computational methods to carry out in silico screening on a massive scale to discover new leads for drugs quickly and cost-effectively. Initial projects are focused on cancer research, though other indications will be added in due course.